Lantheus Holdings, Inc. Asset Retirement Obligation, Revision of Estimate
Lantheus Holdings, Inc. (LNTH) reported Asset Retirement Obligation, Revision of Estimate of $4.70 million for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationRevisionOfEstimate · last filed 2026-08-06
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for the quarter ending 2025-12-31 was $9.43M.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for the quarter ending 2025-09-30 was -$1.10M.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for the quarter ending 2025-06-30 was -$27.00K.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for the quarter ending 2025-03-31 was -$4.70M.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for fiscal 2022 was $280.00K, a 94.72% decline from fiscal 2021.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for fiscal 2021 was $5.30M, a 1654.97% increase from fiscal 2020.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for fiscal 2020 was $302.00K, a 1410.00% increase from fiscal 2019.
- Lantheus Holdings, Inc. asset retirement obligation, revision of estimate for fiscal 2019 was $20.00K.
| Period end | Asset Retirement Obligation, Revision of Estimate 3 month | Asset Retirement Obligation, Revision of Estimate 3 month as first filed | Asset Retirement Obligation, Revision of Estimate 6 month | Asset Retirement Obligation, Revision of Estimate 9 month | Asset Retirement Obligation, Revision of Estimate 12 month | Asset Retirement Obligation, Revision of Estimate 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $9.43M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $8.33M derived: sum of 2 quarters · filed 2026-08-06 | $8.30M derived: sum of 3 quarters · filed 2026-08-06 | $4.70M 10-Q · filed 2026-08-06 | -$4.73M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$1.10M 10-Q · filed 2025-11-06 | -$1.13M derived: sum of 2 quarters · filed 2025-11-06 | -$4.73M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$4.73M 10-Q · filed 2025-08-06 | ||||
| 2025-03-31 | -$4.70M 10-Q · filed 2025-11-06 | -$4.73M 10-Q · filed 2025-05-07 | ||||
| 2022-12-31 | $280.00K 10-K · filed 2024-02-22 | |||||
| 2021-12-31 | $5.30M 10-K · filed 2023-02-23 | $5.26M 10-K · filed 2022-02-24 | ||||
| 2020-12-31 | $302.00K 10-K · filed 2021-02-25 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $20.00K 10-K · filed 2020-02-25 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $20.00K 10-Q · filed 2019-10-31 | ||||
| 2019-06-30 | $20.00K 10-Q · filed 2019-07-25 | |||||
| 2016-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $537.00K derived: sum of 2 quarters · filed 2017-02-23 | $537.00K derived: sum of 3 quarters · filed 2017-02-23 | $576.00K 10-K · filed 2017-02-23 | ||
| 2016-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $283.00K derived: sum of 2 quarters · filed 2016-11-01 | $322.00K 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $39.00K 10-Q · filed 2016-08-04 | ||||
| 2016-03-31 | $39.00K 10-Q · filed 2016-05-03 | |||||
| 2015-12-31 | -$37.00K 10-K · filed 2017-02-23 | |||||
| 2014-12-31 | $277.00K 10-K · filed 2017-02-23 | |||||
| 2013-12-31 | $341.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |